What is it about?
Patients with asthma-COPD overlap could be identified from asthma and COPD by the expression profiles of five miRNAs in plasma, especially miR-15b-5p. The combined assessment of miR-15b-5p, periostin, and YKL-40 was valuable for characterizing ACO.
Featured Image
Photo by Science in HD on Unsplash
Why is it important?
Plasma levels of miR-15b-5p can serve as a potential biomarker for identifying patients with asthma-COPD overlap (ACO), while also furthering our understanding of the pathophysiology of ACO.
Perspectives
It is considered that elucidation of the role of miR-15b-5p in the pathophysiology of ACO will contribute to the development of precision medicine for ACO, asthma, and COPD.
Keita Hirai
University of Shizuoka
Read the Original
This page is a summary of: Circulating microRNA‐15b‐5p as a biomarker for asthma‐COPD overlap, Allergy, July 2020, Wiley,
DOI: 10.1111/all.14520.
You can read the full text:
Resources
Contributors
The following have contributed to this page
